Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,678 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05468970Recruiting
Study of bone and soft tissue tumors and treatment outcomes
This study looks at people with bone or soft tissue tumors to understand their features, treatments used, and survival outcomes. It may help doctors learn which care approaches work best for different tumor subtypes.
Zhengzhou, HenanAges 6–99 - NCT05469087Recruiting
Study of primary hyperparathyroidism in adults
This study follows adults with primary hyperparathyroidism (a hormone-related condition that affects calcium levels). It aims to better understand the condition and who it affects, which may help improve care over time.
Nantes, Loire-AtlantiqueAges 18 years+ - NCT05469945Recruiting
Prevention study for leg swelling after gynecologic cancer treatment
This study looks at what to do to help prevent or better manage leg swelling (lymphedema) after treatment for certain gynecologic cancers. You may be asked to use a diary or app and complete questionnaires so the team can track symptoms over time.
GhentAges 18–99 - NCT05470920Recruiting
Genetic testing help tool for ovarian or pancreatic cancer
This study tests a decision aid that helps people with ovarian or pancreatic cancer understand and decide about genetic (inherited) testing. It may help you make a clearer choice about next steps for yourself and your family.
Boston, MassachusettsAges 18 years+ - NCT05470335Recruiting
Nurse-led heart procedure setup for suspected heart artery disease
This study checks whether a nurse-led technique for placing a sheath (a small tube used during a heart test/procedure) works safely in people suspected of blocked heart arteries. If you qualify, your care team will guide the process and compare how it goes with standard approaches.
Roskilde, DanmarkAges 18 years+ - NCT05472558RecruitingPhase 1
CAR-NK cell treatment for CD19-positive relapsed lymphoma
This Phase 1 study tests a new immune-cell treatment made from donated cord blood. It aims to treat people whose B-cell lymphoma has come back or did not respond, specifically when the tumor has CD19 on it.
Hanzhou, ZhejiangAges 18–75 - NCT05473637Recruiting
Study causes of small vessel brain disease in stroke and memory issues
This trial looks at people who may have “small vessel” problems in the brain, which can cause stroke, memory trouble, walking changes, movement symptoms, or headaches. It may help researchers better understand the genetic and non-genetic causes, which could improve future diagnosis and treatment.
TaipeiAges 18 years+ - NCT05473520RecruitingPhase 3
Doxycycline add-on therapy for lung improvement in tuberculosis
This Phase 3 trial tests whether adding doxycycline to standard TB medicine can improve lung function and reduce lung tissue damage. It aims to see if patients recover better by targeting the lung response to TB.
Kota Kinabalu, SabahAges 21 years+ - NCT05474196Recruiting
Monitoring pressures in the lungs for people with ARDS
This trial studies how pressure measurements from a special breathing and temperature monitoring system relate to fluid outside the lung blood vessels in people with ARDS. It may help doctors understand what those measurements mean and how to monitor patients more accurately.
Le Kremlin-BicêtreAges 18 years+ - NCT05475015Recruiting
3D MRI scan to assess liver scarring and pressure
This study tests whether a special 3D MRI scan (3D-MRE) can measure liver scarring and the high pressure in the liver called portal hypertension. It may help your team use imaging to understand how severe your liver disease is, especially when a pressure test (HVPG) is being considered.
Shenyang, LiaoningAges 18–75 - NCT05475574Recruiting
Stopping extra cleaning for some resistant bacteria in geriatrics
This trial looks at whether stopping extra “contact precautions” (special measures to prevent spread) is safe for older hospital patients who carry a certain type of hard-to-treat gut bacteria. It may reduce unnecessary isolation and improve comfort, while still aiming to prevent infections.
MetzAges 65 years+ - NCT05475613RecruitingPhase 2
Immunotherapy to shrink advanced liver cancer before transplant
This trial tests an immunotherapy “downstaging” plan to shrink hepatocellular carcinoma (a type of liver cancer) so it may become treatable with a liver transplant. You may be eligible if your cancer is beyond transplant limits but is still only in the liver, and you meet specific liver function and health requirements.
Guangzhou, GuangdongAges 18–75 - NCT05476627Recruiting
Study risk factors for kidney disease from metabolic conditions
This study looks at risk factors and body “omics” information (like blood/tissue patterns) to better understand chronic kidney disease caused by metabolic diseases. It may help researchers find better ways to predict or manage kidney problems in people with these conditions.
Beijing, Beijing MunicipalityAges 18–80 - NCT05477979Recruiting
Study how stress affects lung cancer treatment outcomes
This study looks at whether psychological stress changes how well lung cancer treatments work and what the outlook is. You may qualify if you’re about to start (or recently started) certain immunotherapy-based treatments, and you can complete stress and well-being questionnaires.
Changsha, HunanAges 18 years+ - NCT05479006Recruiting
tDCS for arm weakness after stroke
This trial tests whether a targeted, noninvasive brain stimulation (tDCS) can improve arm weakness and movement after stroke. It may help people who have significant trouble moving one arm on the side affected by stroke.
Urbana, IllinoisAges 18–90 - NCT05479617Recruiting
Predicting ulcerative colitis flare course using personal data
This study tries to better predict how an ulcerative colitis flare will progress by using a mix of your medical information. If you are eligible, your flare details may help researchers build tools that guide future care.
Hvidovre, DenmarkAges 18 years+ - NCT05479448Recruiting
Tracking what predicts response in new PMR or GCA
This study looks at people newly diagnosed with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA) and uses their health and treatment information to learn what predicts how well treatment works. It may help your care in the future by improving which patients respond best and how.
BaselAges 18 years+ - NCT05480150Recruiting
Study of brain and mood in people with depression or bipolar disorder
This study is following and assessing people with major depression or bipolar disorder to better understand the condition and how the brain relates to symptoms. It may help researchers develop more targeted support by comparing brain and health information over time.
Hangzhou, ZhejiangAges 16–65 - NCT05480319Recruiting
Testing a cardiac arrest response system in the emergency room
This trial checks whether a new emergency-room system helps respond faster and more consistently when someone has a cardiac arrest. If you are eligible, you may be included while you are treated in the emergency department.
TaipeiAges 20 years+ - NCT05481619RecruitingPhase 4
Vedolizumab study for ulcerative colitis and gut changes
This trial tests whether vedolizumab helps people with moderate-to-severe ulcerative colitis and what changes happen in the gut microbiome (the community of helpful bacteria in your intestines). You may be able to join if you’re an adult with ulcerative colitis who has not used vedolizumab before and haven’t taken certain gut-affecting medicines recently.
Zhengzhou, HangzhouAges 18 years+ - NCT05482269Recruiting
Using CT scans to predict outcomes after lung blood clots
This trial uses an artificial intelligence (AI) system to read CT scan images of the lungs and predict outcomes after a pulmonary embolism (a blood clot in the lung). It may help doctors identify who is at higher risk, so treatment decisions can be faster and more accurate.
Shenyang, LiaoningAges 18 years+ - NCT05482906Recruiting
Smartphone and MRI study for people with multiple sclerosis
This study looks at how information from a brain/spinal MRI and a smartphone relates to walking and daily function in people with multiple sclerosis (MS). It may help researchers understand what signals predict changes over time.
Nantes, Loire-AtlantiqueAges 18 years+ - NCT05482607Recruiting
CT scan pattern study in lung disease from systemic sclerosis
This study looks at patterns seen on a high-resolution CT (HRCT) scan to better understand lung disease that can occur with systemic sclerosis. It may help doctors recognize which lung changes go with which type of disease.
NancyAges 18 years+ - NCT05482945RecruitingPhase 2
Argon treatment for certain out-of-hospital cardiac arrest patients
This Phase 2 trial tests whether breathing “argon” through a breathing device, started soon after successful CPR, can improve recovery in adults who had a witnessed, shockable cardiac arrest. It is for ICU patients who were unconscious right after return of heartbeat and meet specific timing and oxygen level requirements.
Genova, GEAges 18 years+
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,678 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.